Allergy

Maryland Becomes Fourth State to Enact Elijah’s Law to Protect Kids with Food Allergies

Retrieved on: 
Freitag, April 26, 2024
Child care, Policy, Territory, Allergy, Asthma, Senate, AAFA, Food, Legislation, Interstate 95 in Maryland, Anaphylaxis, Memory, EAF, Nursing

Wes Moore, enacts policies designed to protect children with food allergies in child care centers.

Key Points: 
  • Wes Moore, enacts policies designed to protect children with food allergies in child care centers.
  • “We commend the state legislature for passing Elijah’s Law and taking steps to ensure uniform practices relative to food allergies in child care centers in Maryland,” said Kenneth Mendez, President and CEO of AAFA.
  • The bill ensures child care centers take steps to manage food allergies for the children in their care.
  • Maryland is the fourth state in the nation to pass Elijah’s Law, following New York, Illinois, and Virginia.

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

Retrieved on: 
Mittwoch, April 24, 2024
Patient, Safety, Pollen, RNA, Allergen, Liver, Allergy, NASAR, Season, ANCOVA, Therapy, MITES, Pharmaceutical industry

HAMILTON, BERMUDA -- April 24, 2024 -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced the publication of the detailed results from the NASAR clinical trial with Bentrio® nasal spray in seasonal allergic rhinitis (SAR). The peer-reviewed article appeared in Allergy,1 which is published by the European Academy of Allergy and Clinical Immunology and recognizes as one of the highest-ranking journals in the field of allergology. Bentrio (AM-301) is a drug-free and preservative-free nasal spray designed to help protect against airborne allergens such as pollen or house dust mites.

Key Points: 
  • Bentrio (AM-301) is a drug-free and preservative-free nasal spray designed to help protect against airborne allergens such as pollen or house dust mites.
  • The primary efficacy endpoint was the reduction in the mean daily reflective Total Nasal Symptom Score (rTNSS; ANCOVA model).
  • Patients and investigators rated the efficacy of treatment as significantly better with Bentrio compared to saline control (both p
  • From 2024 onwards, Altamira Medica expects sales to grow significantly, mainly driven by the launch of Bentrio in additional countries.

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

Retrieved on: 
Mittwoch, Mai 1, 2024
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Mortality, FDA, Risk, ICS, Death, Weight loss, Growth, Gastrointestinal tract, Rash, TSLP, Formoterol, Biopharmaceutical, AstraZeneca, LABA, Inflammation, Salbutamol, Skin, Tezepelumab, Approval, EGPA, AMG, Allergy, Polyp (medicine), Bronchitis, Chronic obstructive pulmonary disease, Patient, Eosinophilic, Sinusitis, Rheumatology, Heart, Atmosphere, Fatigue, Immunology, Budesonide, Lung, Chronic pain, Asthma, COPD, Gastroenterology, Emphysema, Disease, Science, Conditional sentence, Dermatology, Pharmaceutical industry

In addition, we are also collaborating with AstraZeneca on AMG104/AZD8630, an inhaled anti-TSLP compound currently in development for asthma.

Key Points: 
  • In addition, we are also collaborating with AstraZeneca on AMG104/AZD8630, an inhaled anti-TSLP compound currently in development for asthma.
  • Respiratory & Immunology, part of BioPharmaceuticals, is one of AstraZeneca’s main disease areas and is a key growth driver for the Company.
  • With common pathways and underlying disease drivers across respiratory and immunology, AstraZeneca is following the science from chronic lung diseases to immunology-driven disease areas.
  • AstraZeneca’s ambition in Respiratory & Immunology is to achieve disease modification and durable remission for millions of patients worldwide.

truInsights into Pet Allergies: Trupanion Decodes Trends and Provides Tips for Pet Parents

Retrieved on: 
Donnerstag, April 25, 2024
Software, Other Health, Professional Services, Data Management, Consumer, Technology, Health Insurance, Data Analytics, Veterinary, Insurance, Practice Management, Health, Pets, CVA, Pet, Safety, Skin, Allergy, Parent, Cat, Human, Flea, Parasitism, Database, Dog, Bachelor of Veterinary Science, Trupanion

For pet parents concerned about allergies affecting their furry companions, Trupanion consulted with veterinarian and Trupanion General Manager, Dr. Stephen Rose, BVSc (Hons1) M Infotech CVA ACVCHM, for his insights.

Key Points: 
  • For pet parents concerned about allergies affecting their furry companions, Trupanion consulted with veterinarian and Trupanion General Manager, Dr. Stephen Rose, BVSc (Hons1) M Infotech CVA ACVCHM, for his insights.
  • “Allergies, much like in humans, can have broad health implications, affecting skin, ears, eyes, feet, and even internal organs,” said Dr. Rose.
  • “Allergies are less seldom triggered by a singular factor but rather accumulate from multiple triggers, ultimately prompting the need for treatment.
  • For Trupanion-covered pets in North America, the highest number of allergy related claims over the past 3 years occurred in these states or provinces:

Clarity Pediatrics Announces Expansion of Virtual Pediatric ADHD Platform and $10M in Funding

Retrieved on: 
Montag, April 22, 2024
Managed Care, General Health, Professional Services, Family, Telemedicine, Virtual Medicine, Consumer, Mental Health, Health Technology, Children, Practice Management, Finance, Health, Kaiser Permanente, American Academy, Investment, ARR, Medicaid, ADHD, BPT, Ginger, Pediatrics (journal), UCSF, Stanford University, Patient, Physician, Medicine, City, Allergy, Function (mathematics), Asthma, Growth, Prevalence, Rock Health, Nursing

Clarity Pediatrics , a digital health company reimagining pediatric chronic care, announced today the expansion of their pediatric ADHD platform and $10M in seed funding led by Rethink Impact with participation from Homebrew and Maverick Ventures .

Key Points: 
  • Clarity Pediatrics , a digital health company reimagining pediatric chronic care, announced today the expansion of their pediatric ADHD platform and $10M in seed funding led by Rethink Impact with participation from Homebrew and Maverick Ventures .
  • This investment supports Clarity Pediatrics’ launch of new clinical service lines, further development of their innovative care platform, and geographic expansion.
  • The cornerstone of Clarity Pediatrics’ approach to ADHD care is Behavioral Parent Training (BPT), recommended by the American Academy of Pediatrics for families of children ages 5 to 12 with mild-moderate ADHD.
  • Clarity Pediatrics makes pediatric ADHD care 10x more accessible and 20x more affordable: families have access to next-day appointments, including for ADHD diagnostic screening and medication-related services, and pay an average co-pay of $15 per session.

ModMed® Ranks #1 for Integrated Practice Management, Revenue Cycle Management and EHR in Surgical Specialties by Black Book Research for Sixth Consecutive Year

Retrieved on: 
Dienstag, April 16, 2024
Health Technology, Health Insurance, Data Management, Technology, Finance, Consulting, Surgery, Practice Management, Managed Care, Professional Services, Hospitals, Artificial Intelligence, Software, Data Analytics, Health, Electronic health record, Gastroenterology, Revenue cycle management, Ophthalmology, ENT, EHR, Urology, Dermatology, OBGYN, Senior, Pain management, Face, Practice management software, Multimedia, Allergy, Podiatry, Nursing

Specialty-specific healthcare technology leader ModMed® today announced its #1 ranking by Black Book™ Research for the sixth year in a row for Integrated Practice Management, Revenue Cycle Management and Electronic Health Record (EHR) in Surgical Specialties.

Key Points: 
  • Specialty-specific healthcare technology leader ModMed® today announced its #1 ranking by Black Book™ Research for the sixth year in a row for Integrated Practice Management, Revenue Cycle Management and Electronic Health Record (EHR) in Surgical Specialties.
  • "We are thrilled that ModMed has been recognized as the top provider of comprehensive solutions for the sixth year in a row.
  • Our solutions go beyond the traditional boundaries, fostering collaborative environments that enhance efficiency and performance," said Rob Ware, Senior Vice President of Revenue Cycle Management at ModMed.
  • Raman Mahabir, MD at Tucson Plastic Surgery, LLC, uses ModMed’s integrated Practice Management and EHR solutions at his practice.

Global Digital Personalized Nutrition Market Outlook & Forecast 2024-2029 Featuring Prominent Vendors - Nutrigenomix, 23andMe, Viome, Noom, and Atlas Biomed - ResearchAndMarkets.com

Retrieved on: 
Donnerstag, April 11, 2024
Health Technology, Health, Fitness & Nutrition, USD, Internet, Safety, Risk, MHealth, Skin, Diabetes, Intake, Heart rate, Exercise, Food, Tablet, Diet, Developed country, Privacy, Electronics, Athlete, Hacks, Allergy, Algorithm, Growth

North America held the largest global digital personalized nutrition market share, accounting for over 42% in 2023.

Key Points: 
  • North America held the largest global digital personalized nutrition market share, accounting for over 42% in 2023.
  • The increasing penetration of smartphones enables more consumers to easily access digital personalized nutrition services, thus driving the digital customized nutrition market.
  • The direct consumer end-user segment is expected to be the largest revenue segment of the global digital personalized nutrition market.
  • The global digital personalized nutrition market by application is segmented into generic health & fitness, disease-based, and sports nutrition.

Allergy & Asthma Network Announces Trusted Messengers Health Equity Community Outreach Plans for 2024

Retrieved on: 
Mittwoch, April 24, 2024
Education, Dermatitis, Health equity, Risk, Travel, Allergy, Health, Research, City, Partnership, Messenger, Asthma, Irritant, Smartphone, Allergen, Food, Trust (social science), RN, Self-management, Trust, Diagnosis, Death, Quality of life, Prevalence, Pharmaceutical industry

FAIRFAX, Va., April 24, 2024 /PRNewswire/ -- Allergy & Asthma Network, the leading nonprofit outreach, education, advocacy and research organization for adults and children living with asthma, allergies and related conditions, announces its Trusted Messengers program community outreach plans for 2024.

Key Points: 
  • FAIRFAX, Va., April 24, 2024 /PRNewswire/ -- Allergy & Asthma Network, the leading nonprofit outreach, education, advocacy and research organization for adults and children living with asthma, allergies and related conditions, announces its Trusted Messengers program community outreach plans for 2024.
  • Trusted Messengers is an award-winning health equity program that involves community outreach to increase awareness and education about asthma, allergies and related conditions.
  • Allergy & Asthma Network plans to offer virtual asthma coaching to no less than 500 people in 2024.
  • The Trusted Messengers Community Outreach program partners with community groups that hold health fairs and events to promote awareness and patient education for people in under-resourced communities.

all® free clear Announces First-Ever Chief Dermatology Advisor

Retrieved on: 
Mittwoch, April 24, 2024
Part, EPA, Skin, Dermatology, Cosmetics, Marketing, Acceptance, Pollen, Skin care, NEA, Pediatrics, Family, Patient, Allergy

STAMFORD, Conn., April 24, 2024 /PRNewswire/ -- all® free clear, the #1 detergent brand recommended by dermatologists for sensitive skin, today announced it is partnering with Dr. Lindsey Zubritsky – a board certified dermatologist and one of social media's most-followed "derm-fluencer" voices, encompassing more than two million followers across Instagram  and TikTok—as the brand's first-ever Chief Dermatology Advisor.

Key Points: 
  • Providing her expertise and serving as a liaison between all® free clear and consumers, the aim is to send a clear message: skin care can also happen in the laundry room.
  • Dr. Zubritsky will make her debut as Chief Dermatology Advisor for the all® free clear brand on the most-watched daytime talk show The View on May 8, 2024, at 11:00 a.m.
  • That's why I recommend a detergent brand like all® free clear for my patients and my own family.
  • all® free clear is the #1 detergent brand recommended for sensitive skin by dermatologists, allergists and pediatricians.

Cymbiotika Launches New Pet Line, Elevating Pet Health with 4 New Supplements: Probiotic+, Calm, Hip & Joint, and Allergy & Immune Health

Retrieved on: 
Dienstag, April 23, 2024
Relaxation, Pet, Mineral, Skin, MSM, Allergy, Health, Face, Nutrient, Antioxidant, Chondroitin, Anxiety, Glucosamine, SAN

The new line includes four revolutionary products: Probiotic+, Calm, Hip & Joint, and Allergy & Immune Health, each formulated with premium ingredients to support optimal pet health.

Key Points: 
  • The new line includes four revolutionary products: Probiotic+, Calm, Hip & Joint, and Allergy & Immune Health, each formulated with premium ingredients to support optimal pet health.
  • Probiotic+ is a groundbreaking formula designed to address core pet health issues by focusing on digestive well-being.
  • This innovative product features trademarked pre-, pro-, and post-biotics that synergistically facilitate a healthy gut environment and long-term well-being.
  • Organic herbs are included to soothe and heal the digestive organs, making Probiotic+ a comprehensive solution for digestive health.